Related posts:

1. Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders...
2. Seaside Therapeutics Initiates Phase 2b Study Of STX209 In Autism Spectrum Disorders Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 2b study to evaluate the effects of STX209 (arbaclofen) on social impairment in children, adolescents and adults (ages 5 to 21) with autism spectrum disorders (ASD). The Company announced positive results from an open-label Phase 2a study of STX209 in September of […]...
3. Mood And Experience: Life Comes At You Living through weddings or divorces, job losses and children’s triumphs, we sometimes feel better and sometimes feel worse. But, psychologists observe, we tend to drift back to a “set point”-a stable resting point, or baseline, in the mind’s level of contentment or unease. Research has shown that the set points for depression and anxiety are […]...
4. Abusing Children With Drugs Under Recognized, US Study A new US study found that giving children drugs for malicious reasons, which is not classed as a form of child abuse and perhaps should be, is an under recognized national problem. A report on the study, by Dr Shan Yin from the University of Colorado in Denver and the Rocky Mountain Poison Drug Center […]...
5. Share of Cost, World’s Largest ADHD Study Underway At UQ, Australia Brisbane researchers are almost halfway through the biggest ever study into Attention Deficit Hyperactivity Disorder (ADHD) – and they are seeking additional research participants. Queensland Brain Institute neuroscientists are hoping to study more than 600 families, as they work towards identifying risk genes for the disorder....
6. Study Linking Autism To MMR Vaccine “An Elaborate Fraud” Study Linking Autism To MMR Vaccine "An Elaborate Fraud"...
7. Study Shows Promise For New Drug To Treat Fragile X Study Shows Promise For New Drug To Treat Fragile X...
8. Leading Researchers To Share New Treatments At Fragile X International Conference Accelerated research findings leading to potentially significant new treatments for fragile X syndrome (FXS) will be presented to nearly 1,000 family members and professionals at the 12th International Fragile X Conference in Dearborn July 21-25…...
9. Dietary Issues In Children With Autism Spectrum Disorders Children with autism spectrum disorders (ASD) can demonstrate feeding problems, food refusal, and limited food preferences from infancy, but energy intake and growth are not affected…...
10. Pharmacoeconomic Value Of Addiction Treatments, Including VIVITROL(R), Published In Leading Healthcare Policy Journal Alkermes, Inc. (NASDAQ: ALKS) today announced the publication of two new studies in the June issue of The American Journal of Managed Care1,2 evaluating pharmacoeconomic data on addiction treatments, including VIVITROL® (naltrexone for extended-release injectable suspension), with the endpoint of total healthcare costs....
11. First Study Of Resiliency On The Battlefield Led By MSU First Study Of Resiliency On The Battlefield Led By MSU...
12. Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...